{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:04:18Z","timestamp":1765609458233,"version":"3.48.0"},"reference-count":46,"publisher":"BMJ","issue":"7","funder":[{"name":"Netherlands Cardiovascular Research Initiative"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,5,14]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In current practice, probands are asked to inform relatives about the possibility of predictive DNA testing when a pathogenic variant causing an inherited cardiac condition (ICC) is identified. Previous research on the uptake of genetic counselling and predictive DNA testing in relatives suggests that not all relatives are sufficiently informed. We developed a randomised controlled trial to evaluate the effectiveness of a tailored approach in which probands decide together with the genetic counsellor which relatives they inform themselves and which relatives they prefer to have informed by the genetic counsellor. Here, we present the study protocol of this randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicentre randomised controlled trial with parallel-group design will be conducted in which an intervention group receiving the tailored approach will be compared with a control group receiving usual care. Adult probands diagnosed with an ICC in whom a likely pathogenic or pathogenic variant is identified will be randomly assigned to the intervention or control group (total sample: n=85 probands). Primary outcomes are uptake of genetic counselling and predictive DNA testing by relatives (total sample: n=340 relatives). Secondary outcomes are appreciation of the approach used and impact on familial and psychological functioning, which will be assessed using questionnaires. Relatives who attend genetic counselling will be asked to fill out a questionnaire as well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained from the Medical Ethical Committee of the Amsterdam University Medical Centres (MEC 2017-145), the Netherlands. All participants will provide informed consent prior to participation in the study. Results of the study on primary and secondary outcome measures will be published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NTR6657; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-025660","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:24:30Z","timestamp":1562675070000},"page":"e025660","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"9","author":[{"given":"Lieke M","family":"van den Heuvel","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne M","family":"Hoedemaekers","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette F","family":"Baas","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Peter","family":"van Tintelen","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen M A","family":"Smets","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imke","family":"Christiaans","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"2025121222521125000_9.7.e025660.1","doi-asserted-by":"publisher","DOI":"10.1159\/000350825"},{"key":"2025121222521125000_9.7.e025660.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902923"},{"key":"2025121222521125000_9.7.e025660.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn219"},{"key":"2025121222521125000_9.7.e025660.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.05.036"},{"key":"2025121222521125000_9.7.e025660.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2013.108"},{"key":"2025121222521125000_9.7.e025660.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-012-9544-4"},{"key":"2025121222521125000_9.7.e025660.7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10689-015-9842-8","article-title":"Genetic testing for Lynch syndrome: family communication and motivation","volume":"15","author":"Leenen","year":"2016","journal-title":"Fam Cancer"},{"key":"2025121222521125000_9.7.e025660.8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajmg.a.37455","article-title":"Factors influencing uptake of familial long QT syndrome genetic testing","volume":"170A","author":"Burns","year":"2016","journal-title":"Am J Med Genet A"},{"key":"2025121222521125000_9.7.e025660.9","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.92"},{"key":"2025121222521125000_9.7.e025660.10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ajmg.a.32672","article-title":"Family letters are an effective way to inform relatives about inherited cardiac disease","volume":"149A","author":"van der Roest","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2025121222521125000_9.7.e025660.11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201206"},{"key":"2025121222521125000_9.7.e025660.12","doi-asserted-by":"crossref","first-page":"127-135","DOI":"10.1007\/s10689-018-0089-z","article-title":"The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice","volume":"18","author":"Menko","year":"2019","journal-title":"Fam Cancer"},{"key":"2025121222521125000_9.7.e025660.13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1399-0004.2007.00912.x","article-title":"The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP","volume":"72","author":"Ramsoekh","year":"2007","journal-title":"Clin Genet"},{"key":"2025121222521125000_9.7.e025660.14","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.81"},{"key":"2025121222521125000_9.7.e025660.15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s10897-010-9314-0","article-title":"Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences","volume":"19","author":"Smart","year":"2010","journal-title":"J Genet Couns"},{"key":"2025121222521125000_9.7.e025660.16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10897-014-9783-7","article-title":"Disclosing Genetic Information to Family Members About Inherited Cardiac Arrhythmias: An Obligation or a Choice?","volume":"24","author":"Vavolizza","year":"2015","journal-title":"J Genet Couns"},{"key":"2025121222521125000_9.7.e025660.17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10897-016-9974-5","article-title":"Family Communication in Inherited Cardiovascular Conditions in Ireland","volume":"25","author":"Whyte","year":"2016","journal-title":"J Genet Couns"},{"key":"2025121222521125000_9.7.e025660.18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10897-014-9774-8","article-title":"Family communication in a population at risk for hypertrophic cardiomyopathy","volume":"24","author":"Batte","year":"2015","journal-title":"J Genet Couns"},{"key":"2025121222521125000_9.7.e025660.19","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318164540b"},{"key":"2025121222521125000_9.7.e025660.20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2350-15-33","article-title":"Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention","volume":"15","author":"Hodgson","year":"2014","journal-title":"BMC Med Genet"},{"key":"2025121222521125000_9.7.e025660.21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ejhg.2015.122","article-title":"Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication","volume":"24","author":"Hodgson","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2025121222521125000_9.7.e025660.22","doi-asserted-by":"crossref","unstructured":"Kinnamon DD , Morales A , Bowen DJ , et al . Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study. Circ Cardiovasc Genet 2017;10.doi:10.1161\/CIRCGENETICS.117.001826","DOI":"10.1161\/CIRCGENETICS.117.001826"},{"key":"2025121222521125000_9.7.e025660.23","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.051581"},{"key":"2025121222521125000_9.7.e025660.24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10689-015-9854-4","article-title":"The impact of an interventional counselling procedure in families with a BRCA1\/2 gene mutation: efficacy and safety","volume":"15","author":"Sermijn","year":"2016","journal-title":"Fam Cancer"},{"key":"2025121222521125000_9.7.e025660.25","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.039172"},{"key":"2025121222521125000_9.7.e025660.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03587-X"},{"key":"2025121222521125000_9.7.e025660.27","first-page":"120","article-title":"A Duty To Warn Relatives in Clinical Genetics: Arguably \u2019Fair just and reasonable' in English Law?","volume":"32","author":"Mitchell","year":"2016","journal-title":"Tottels J Prof Neglig"},{"key":"2025121222521125000_9.7.e025660.28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bioe.12176","article-title":"The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information","volume":"30","author":"Weaver","year":"2016","journal-title":"Bioethics"},{"key":"2025121222521125000_9.7.e025660.29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/humu.23118","article-title":"Am I My Family\u2019s Keeper? Disclosure Dilemmas in Next-Generation Sequencing","volume":"37","author":"Wouters","year":"2016","journal-title":"Hum Mutat"},{"key":"2025121222521125000_9.7.e025660.30","unstructured":"Leonard SJ , Newson AJ . Ethical perspectives. In: Gaff CL , Bylund CL , Family communication about genetics: Theory and practice. New York: Oxford University Press, inc, 2010."},{"key":"2025121222521125000_9.7.e025660.31","first-page":"506","article-title":"SPIRIT 2013 Statement: defining standard protocol items for clinical trials","volume":"38","author":"Chan","year":"2015","journal-title":"Rev Panam Salud Publica"},{"key":"2025121222521125000_9.7.e025660.32","unstructured":"Castor BV . Castor electronic data capture. Amsterdam, 2016."},{"key":"2025121222521125000_9.7.e025660.33","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.pec.2018.05.009","article-title":"How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial","volume":"101","author":"Eijzenga","year":"2018","journal-title":"Patient Educ Couns"},{"key":"2025121222521125000_9.7.e025660.34","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199705000-00010"},{"key":"2025121222521125000_9.7.e025660.35","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0b013e3182813a17"},{"key":"2025121222521125000_9.7.e025660.36","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291796004382"},{"key":"2025121222521125000_9.7.e025660.37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1611(199903\/04)8:2<155::AID-PON350>3.0.CO;2-A"},{"key":"2025121222521125000_9.7.e025660.38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0191-8869(96)00029-3","article-title":"Coping with medical threat: An evaluation of the Threatening Medical Situations Inventory (TMSI)","volume":"21","author":"van Zuuren","year":"1996","journal-title":"Pers Individ Dif"},{"issue":"1-3","key":"2025121222521125000_9.7.e025660.39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pec.2007.07.001","article-title":"Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk","volume":"69","author":"Wakefield","year":"2007","journal-title":"Patient Educ Couns"},{"key":"2025121222521125000_9.7.e025660.40","first-page":"6","article-title":"Assessment of state and trait anxiety: Conceptual and methodological issues","volume":"2","author":"Spielberger","year":"1985","journal-title":"South Psychol"},{"key":"2025121222521125000_9.7.e025660.41","unstructured":"Van der Ploeg HM , Spielberger CD . Handleiding bij de Zelf-Beoordelings Vragenlijst ZBV. Een Nederlandse bewerking van de Spielberger State-Trait Anxiety Inventory STAI-DY. Lisse: Swets & Zeitlinger, 1981."},{"key":"2025121222521125000_9.7.e025660.42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12529-014-9455-x","article-title":"Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives","volume":"22","author":"de Geus","year":"2015","journal-title":"Int J Behav Med"},{"key":"2025121222521125000_9.7.e025660.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2012.07.014"},{"key":"2025121222521125000_9.7.e025660.44","unstructured":"SPSS Inc. IBM SPSS Statistics for Windows. Armonk (NY): IBM, 2016."},{"key":"2025121222521125000_9.7.e025660.45","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025121222521125000_9.7.e025660.46","unstructured":"VERBI Software. MAXQDA Analytics Pro 12 ed. Berlin, Germany: VERBI, 2016."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-025660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:52:23Z","timestamp":1765608743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-025660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,9]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bmjopen-2018-025660"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-025660","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}